Cargando…

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Over recent years, mesenchymal stem/stromal cells (MSCs) and their potential biomedical applications have received much attention from the global scientific community in an increasing manner. Firstly, MSCs were successfully isolated from human bone marrow (BM), but in the next steps, they were also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markov, Alexander, Thangavelu, Lakshmi, Aravindhan, Surendar, Zekiy, Angelina Olegovna, Jarahian, Mostafa, Chartrand, Max Stanley, Pathak, Yashwant, Marofi, Faroogh, Shamlou, Somayeh, Hassanzadeh, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971361/ https://www.ncbi.nlm.nih.gov/pubmed/33736695 http://dx.doi.org/10.1186/s13287-021-02265-1

Ejemplares similares

Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
por: Marofi, Faroogh, et al.
Publicado: (2021)

Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell
por: Shojaei Baghini, Sadegh, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
por: Ghaebi, Mahnaz, et al.
Publicado: (2021)

Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
por: Rahbaran, Mohaddeseh, et al.
Publicado: (2022)

CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)

A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021)

Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements
por: Rahbaran, Mohaddeseh, et al.
Publicado: (2021)

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022)

Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape
por: Jarahian, Mostafa, et al.
Publicado: (2021)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
por: Razeghian, Ehsan, et al.
Publicado: (2021)

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021)

Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2021)

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment
por: Malekpour, Kosar, et al.
Publicado: (2021)

Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro
por: Alkafaji, Haider A., et al.
Publicado: (2021)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021)

Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
por: Nakhaei, Pooria, et al.
Publicado: (2021)

Psychometric Validation of the Persian Version of the COVID-19-Related Psychological Distress Scale and Association with COVID-19 Fear, COVID-19 Anxiety, Optimism, and Lack of Resilience
por: Nazari, Nabi, et al.
Publicado: (2021)

Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer
por: Marofi, Faroogh, et al.
Publicado: (2017)

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
por: Shomali, Navid, et al.
Publicado: (2022)

Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
por: Dauletova, Meruyert, et al.
Publicado: (2021)

The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
por: Zeinalzadeh, Elham, et al.
Publicado: (2021)

Tribbles homolog 2 (Trib2), a pseudo serine/threonine kinase in tumorigenesis and stem cell fate decisions
por: Fang, Yu, et al.
Publicado: (2021)

Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
por: Yaghoubi, Sajad, et al.
Publicado: (2021)

Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature
por: Aravindhan, Surendar, et al.
Publicado: (2021)

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
por: Sajjadi-Dokht, Mehdi, et al.
Publicado: (2021)

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

An Overview of In Vitro, In Vivo, and Computational Techniques for Cancer-Associated Angiogenesis Studies
por: Rahman, Heshu Sulaiman, et al.
Publicado: (2020)

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
por: Vafaei, Somayeh, et al.
Publicado: (2022)

Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
por: Yari, Hadi, et al.
Publicado: (2022)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
por: Daei Sorkhabi, Amin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ergiog5c4a4m79g4rk16eirvh4